Company / FCF Margin
Harmony Biosciences Holdings, Inc. FCF Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
40.1%
FY2025
5-year range
-1260.8% / 40.1%
FY2021-FY2025
Trend
+31.0%
vs FY2024
Sector context
#9 of 133
Health Care
What the data says
Among 133 Health Care companies, Harmony Biosciences Holdings, Inc. is in the top 7% for fcf margin. Improved from 37.6% to 40.1% over the past 2 years.
Based on SEC 10-K filings.
40.1% in FY2025 with a 5-year CAGR of +1300.9%. Top quartile in the Health Care sector.
Improved from 37.6% to 40.1% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +7.1pp
- 5-Year Change
- +1300.9pp
- 10-Year Change
- -
Sector benchmark
Top 7% in Health CareTop 7% of 133This company 40.1% Sector average -632.8%
▼
+106.3% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 31.0% year-over-year.
- Currently 672.9pp above the Health Care sector average.
- Lowest fcf margin in the period was in FY2021.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 40.1% | +31.0% |
| FY2024 | 30.6% | -18.7% |
| FY2023 | 37.6% | +14.2% |
| FY2022 | 33.0% | +102.6% |
| FY2021 | -1260.8% | +0.0% |
| FY2020 | -1260.8% | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026